The Connecticut Division of Shopper Safety (DCP) has tapped the previous CEO of the state’s first licensed hashish grower as state program supervisor for hashish, CT Insider stories. Jennifer Mandzuk labored at Theraplant from 2014 till January and served as the corporate’s CEO since July 2022, the report says.
DCP spokesperson Kaitlyn Krasselt informed Insider that “Companies usually rent material specialists from the trade to make sure prime quality, skilled workers.”
“There isn’t any formal battle of curiosity when a former worker of an trade that we regulate involves work for the regulating company. … There isn’t any requirement to acquire a proper approval from the Workplace of the State Ethics.” — Krasselt to CT Insider
The state ethics workplace informed Insider that the state’s code of ethics “doesn’t comprise a blanket prohibition towards a present public official making choices that may have an effect on his or her former employer.”
From 2019 to 2020, Theraplant spent $337,213.45 on lobbying efforts, in line with a CT Post report in March. In 2021 and 2022 the agency spent $320,974.35, the report says.
Theraplant is one among 4 lively hashish cultivators within the state, and was the primary when medical hashish was legalized in 2015. The corporate was acquired by Greenrose Holding in 2021, and once more this 12 months by New York-based DXR Holdco subsidiary NewCo, in line with Safety and Change Fee filings outlined by Insider.
In line with the job post, the state program supervisor for hashish “is liable for the administration of the hashish program within the Division of Shopper Safety, and could also be liable for administration and oversight of different packages throughout the Drug Management Division and stories to the Director of the Drug Management Division.”
Get each day hashish enterprise information updates. Subscribe